Atara Biotherapeutics, Inc. Quarterly Debt-to-equity in % from Q2 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Atara Biotherapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q2 2015 to Q3 2024.
  • Atara Biotherapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -248 %, a 138% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -248 -900 -138% Sep 30, 2024
Q2 2024 -277 -512 -218% Jun 30, 2024
Q1 2024 -418 -551 -414% Mar 31, 2024
Q4 2023 -1.26K -1.36K -1384% Dec 31, 2023
Q3 2023 651 +575 +757% Sep 30, 2023
Q2 2023 235 +171 +270% Jun 30, 2023
Q1 2023 133 +78.4 +143% Mar 31, 2023
Q4 2022 98.4 +54.1 +122% Dec 31, 2022
Q3 2022 76.1 +41.4 +119% Sep 30, 2022
Q2 2022 63.5 +35.4 +127% Jun 30, 2022
Q1 2022 54.7 +32.5 +146% Mar 31, 2022
Q4 2021 44.2 +25.6 +137% Dec 31, 2021
Q3 2021 34.7 +19.3 +125% Sep 30, 2021
Q2 2021 28 +12.6 +81.2% Jun 30, 2021
Q1 2021 22.2 +5.14 +30.1% Mar 31, 2021
Q4 2020 18.7 +2.6 +16.2% Dec 31, 2020
Q3 2020 15.4 -0.06 -0.39% Sep 30, 2020
Q2 2020 15.5 +1.51 +10.8% Jun 30, 2020
Q1 2020 17.1 +5.34 +45.4% Mar 31, 2020
Q4 2019 16.1 +5.88 +57.5% Dec 31, 2019
Q3 2019 15.5 +5.05 +48.3% Sep 30, 2019
Q2 2019 14 +3.14 +29.1% Jun 30, 2019
Q1 2019 11.8 +0.21 +1.82% Mar 31, 2019
Q4 2018 10.2 -1.15 -10.1% Dec 31, 2018
Q3 2018 10.5 +3.28 +45.7% Sep 30, 2018
Q2 2018 10.8 +5.08 +88.7% Jun 30, 2018
Q1 2018 11.6 +7.39 +178% Mar 31, 2018
Q4 2017 11.4 +7.42 +188% Dec 31, 2017
Q3 2017 7.17 +3.46 +93.2% Sep 30, 2017
Q2 2017 5.73 +2.81 +96.4% Jun 30, 2017
Q1 2017 4.16 +0.76 +22.3% Mar 31, 2017
Q4 2016 3.95 +0.62 +18.6% Dec 31, 2016
Q3 2016 3.71 +0.37 +11.1% Sep 30, 2016
Q2 2016 2.91 -2.42 -45.4% Jun 30, 2016
Q1 2016 3.4 Mar 31, 2016
Q4 2015 3.33 Dec 31, 2015
Q3 2015 3.34 Sep 30, 2015
Q2 2015 5.33 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.